Quick Answer
MYRIAD GENETICS INC reported Total Assets of $706.60 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -31.2% in Total Assets from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2010 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2010: $610.84 million | Q4 2010: $593.61 million | Q1 2011: $557.28 million | Q3 2011: $611.74 million | Q4 2011: $661.26 million | Q1 2012: $699.25 million | Q3 2012: $703.06 million | Q4 2012: $717.75 million | Q1 2013: $729.03 million | Q3 2013: $781.66 million | Q4 2013: $756.68 million | Q1 2014: $816.43 million | Q3 2014: $809.01 million | Q4 2014: $781.85 million | Q1 2015: $779.05 million | Q3 2015: $787.00 million | Q4 2015: $871.70 million | Q1 2016: $868.20 million | Q3 2016: $1.27 billion | Q4 2016: $1.28 billion | Q1 2017: $1.27 billion | Q3 2017: $1.23 billion | Q4 2017: $1.23 billion | Q1 2018: $1.22 billion | Q3 2018: $1.57 billion | Q4 2018: $1.56 billion | Q1 2019: $1.56 billion | Q3 2019: $1.59 billion | Q4 2019: $1.58 billion | Q1 2020: $1.45 billion | Q2 2020: $1.40 billion | Q3 2020: $1.44 billion | Q1 2021: $1.34 billion | Q2 2021: $1.36 billion | Q3 2021: $1.34 billion | Q1 2022: $1.26 billion | Q2 2022: $1.21 billion | Q3 2022: $1.21 billion | Q1 2023: $1.17 billion | Q2 2023: $1.19 billion | Q3 2023: $1.15 billion | Q1 2024: $1.11 billion | Q2 2024: $1.09 billion | Q3 2024: $1.08 billion | Q1 2025: $1.01 billion | Q2 2025: $677.30 million | Q3 2025: $728.10 million.
- Over the full 17 years of available data (2010 to 2025), MYRIAD GENETICS INC's Total Assets has grown by 19.0%.
- Historical annual values: Fiscal year 2025: $706.60 million | Fiscal year 2024: $1.03 billion | Fiscal year 2023: $1.15 billion | Fiscal year 2022: $1.20 billion | Fiscal year 2021: $1.32 billion | Fiscal year 2020: $1.42 billion | Fiscal year 2020: $1.40 billion | Fiscal year 2019: $1.56 billion | Fiscal year 2018: $1.18 billion | Fiscal year 2017: $1.21 billion | Fiscal year 2016: $880.50 million | Fiscal year 2015: $766.20 million | Fiscal year 2014: $823.80 million | Fiscal year 2013: $803.82 million | Fiscal year 2012: $690.64 million | Fiscal year 2011: $610.83 million | Fiscal year 2010: $593.85 million.
- Data sourced from SEC EDGAR public filings as of August 4, 2026.
Last verified: